Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1051 AL 1065

Alzheimer's disease and dementia care in Nigeria: Challenges, realities, and the call for a national strategy

Ndionuka IB.

J Alzheimers Dis. 2026 Apr;110(4):1629-1631. doi: 10.1177/13872877261424254. Epub 2026 Feb 26.

Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial

Atri A, Apostolova LG, Iwata A, Wessels AM, Atkins A, Lu M, Ye W, Ryan S, Doty EG.

Neurol Clin Pract. 2026 Jun;16(3):e200621. doi: 10.1212/CPJ.0000000000200621. Epub 2026 May 13.

Association between diabetes mellitus and risk of Alzheimer's disease: a meta-analysis and systematic review

Wu J, Li J, Qin X, Chen W.

Front Endocrinol (Lausanne). 2026 Mar 3;17:1736410. doi: 10.3389/fendo.2026.1736410. eCollection 2026.

The neuromodulatory fragility hypothesis of Alzheimer's disease pathogenesis

Wearn A, Onuska KM, Schmitz TW, Turner GR, Spreng RN.

Alzheimers Dement. 2026 Mar;22(3):e71249. doi: 10.1002/alz.71249.

Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials

Cummings JL, Atri A, Sano M, Zetterberg H, Scheltens P, Knop FK, Johannsen P, Wichmann CA, Abschneider RM, Leon T, Feldman HH.

Lancet. 2026 May 30;407(10544):2167-2179. doi: 10.1016/S0140-6736(26)00459-9. Epub 2026 Mar 19.

Women's midlife: the front line of Alzheimer prevention

Mosconi L.

J Clin Invest. 2026 Mar 16;136(6):e199832. doi: 10.1172/JCI199832. eCollection 2026 Mar 16.

Interim analysis of all-case post-marketing surveillance study in Japan: lecanemab in patients with early Alzheimer's disease

Iwata A, Sakata Y, Koizumi K, Endo A, Kuang W, Sumitomo K, Ishii M.

J Prev Alzheimers Dis. 2026 May;13(5):100541. doi: 10.1016/j.tjpad.2026.100541. Epub 2026 Mar 17.

Effects of different dietary restriction regimens on cognitive function and pathological markers in Alzheimer's disease mouse models: A systematic review and meta-analysis

Sun L, Xu X, Wang Z, Meng Y, Li Y, Hou Y, Gao X, Cui H, Li Y.

Neurosci Biobehav Rev. 2026 May;184:106601. doi: 10.1016/j.neubiorev.2026.106601. Epub 2026 Feb 8.

Tirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort study

da Silva AMP, Januário Campos Cardoso L, Batista S, Gonçalves OR, Paranhos T, Teixeira IPS, Guimarães PD, Espinosa Franco B, Cal H, Salles JEN, Perry G, Høilund-Carlsen PF, Santos DH.

J Diabetes Complications. 2026 May;40(5):109306. doi: 10.1016/j.jdiacomp.2026.109306. Epub 2026 Feb 25.

Vascular contribution to cognitive impairment and dementia (VCID): proceedings of 2025 workshop of the Jackson Laboratory

Anwer M, Poliakova T, Albanus RD, Bhuiyan MIH, Brickman AM, Chaudhuri S, Cuddy L, Eisenbaum M, Foley K, Gould DB, Hall C, Iadecola C, Marola O, Norris CM, Reagan A, Schneider J, Wilcock D, Xu I, Yang A, Howell G, Wellington CL.

Mamm Genome. 2026 Mar 14;37(1):44. doi: 10.1007/s00335-026-10210-x.

Hypertension as a Major Risk Factor in Alzheimer's Disease: Mechanisms, Interactions and Therapeutic Perspectives

Jiang E, Ullah S, Waheed I, Han J, Zhang X.

Clin Interv Aging. 2026 Mar 7;21:585864. doi: 10.2147/CIA.S585864. eCollection 2026.

Risk of Alzheimer Disease and Related Dementia after Retinal Vascular Occlusion: A Nationwide Cohort Analysis

Tsai HR, Lin YJ, Loh CH, Lee YC, Huang HK.

Ophthalmol Retina. 2026 Feb;10(2):117-127. doi: 10.1016/j.oret.2025.10.017. Epub 2026 Jan 1.

Genetic risk in Alzheimer's disease

Pan Y, Cho H, Lou Q, Zhang W, Asken B, Song Q.

NPJ Syst Biol Appl. 2026 Feb 14;12(1):39. doi: 10.1038/s41540-026-00665-8.

Lecanemab appropriate use recommendations for clinical practice in the UK

Mummery CJ, Rasmussen J, Blackburn D, Coulthard E, Davies RR, Dorsey R, Fox NC, Hosseini AA, Ivenso C, Jones M, Kennelly SP, Kipps C, Lashley D, Mackay G, Negi R, Nilforooshan R, Passmore PA, Perry R, Raymont V, Rowe JB, Russ TC, Taylor JP, Burns A.

J Neurol Neurosurg Psychiatry. 2026 Apr 15;97(5):372-384. doi: 10.1136/jnnp-2025-336597.

How does type 2 diabetes modify the risk of Alzheimer's disease?

Sutherland GT, Chen A, Nguyen-Hao HT, Mundell H, Aladyeva E, Hofer MJ, Harari O, Twigg SM.

Alzheimers Dement. 2026 May;22(5):e71471. doi: 10.1002/alz.71471.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias